2.16MMarket Cap-12P/E (TTM)
0.3713High0.3400Low179.03KVolume0.3671Open0.3560Pre Close63.93KTurnover2.96%Turnover RatioLossP/E (Static)6.29MShares4.650052wk High-2.23P/B2.08MFloat Cap0.324152wk Low--Dividend TTM6.06MShs Float2141994.0840Historical High--Div YieldTTM8.79%Amplitude0.3241Historical Low0.3570Avg Price1Lot Size
Cyclacel Pharmaceuticals Stock Forum
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
Positive
Net loss decreased by 67% to $2.0 million from $6.0 million YoY
R&D expenses reduced by 81% to $1.0 million from $5.2 million YoY
Operating cash burn reduced to $6.6 million from $12.2 million for nine months
Negative
Cash position declined to $3.0 million from $3.4 million at end-2023
Risk of Nasdaq delisting if minimum stockholders' equity requireme...
SEC· 9 mins ago
No comment yet